
Browsing restrictions can be lifted for a fee.
Andes Technology Corporation engages in the research and developing, designing, manufacturing, and marketing of embedded processor intellectual property (IP), related hardware/software developing platform, and toolchains in Taiwan, Mainland China, the United States, and internationally. The company offers AndeStar Architecture, a patented 32-bit/64-bit RISC-style CPU architecture; AndesCore, a series of 32-bit/64-bit CPUs for use in embedded applications; Andes Custom Extension that allows designers design their CPU instructions on the already performance optimized AndesCore processors; and AndeShape Platform that contains various categories of products for system development with AndesCore processors. It also provides AndeSight IDE, an eclipse-based IDE that offers solutions to develop embedded applications; and AndeSoft SW Stack, which provides a set of software components, such as real-time operating system, Linux kernel and drivers, libraries, middleware, and application frameworks. Andes Technology Corporation was incorporated in 2005 is based in Hsinchu, Taiwan.
6533
晶心科
-6.25%
(-0.06)
The most recent financial report for 晶心科 (6533) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 6533's short-term business performance and financial health. For the latest updates on 6533's earnings releases, visit this page regularly.
According to the latest financial report, 晶心科 (6533) reported an Operating Profit of -24.06M with an Operating Margin of -5.16% this period, representing a decline of 200.38% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, 晶心科 (6533) announced revenue of 466.53M, with a Year-Over-Year growth rate of 8.84%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, 晶心科 (6533) held Total Cash and Cash Equivalents of 984.29M, accounting for 0.16 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, 晶心科 (6533) did not achieve the “three margins increasing” benchmark, with a gross margin of 99.97%%, operating margin of -5.16%%, and net margin of 1.81%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 6533's profit trajectory and future growth potential.
According to the past four quarterly reports, 晶心科 (6533)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.17. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
晶心科 (6533)'s Free Cash Flow (FCF) for the period is -1.14B, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 475.4% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.